Investigators profiled NTCP homologs from 23 mammals to probe how receptor and transporter functions diverge. The analysis revealed striking functional heterogeneity among felids. Cat, tiger, and leopard NTCPs supported preS1 binding and permitted HBV infection in the assays reported. Lion-NTCP, by contrast, failed to bind preS1. The team observed that lion-NTCP also showed markedly reduced bile acid transport, indicating a loss of transporter efficiency alongside loss of receptor activity. These paired observations suggest a trade-off: sequence changes that remove viral entry potential can impair physiological transporter function.
The experiments combined comparative functional profiling with targeted mutagenesis and structural modeling. Investigators reported that the feline NTCP variants did not follow a uniform pattern across the genus; instead, individual species carried distinctive substitutions that altered both viral receptor compatibility and bile acid conduction. The study authors emphasized that this heterogeneity was unexpected given prior assumptions that NTCP evolution broadly preserves transporter function while shedding receptor capability.
Mutagenesis localized the critical determinants to two residues. The study team identified substitutions at positions 191 and 268 as decisive for receptor activity. Introducing lion-type changes (G191R and T268A) into cat-NTCP abolished preS1 binding in their assays. Reciprocal substitutions in lion-NTCP restored preS1 binding and receptor function. Short, direct assays confirmed that these two positions alone were sufficient to flip receptor competence between the feline variants tested. The data indicate that relatively small sequence changes can toggle NTCP between a viral-permissive and a viral-resistant state.
Those specific substitutions also correlated with transporter performance. Lion-NTCP’s amino acid profile—associated with resistance to HBV entry—coincided with a notable reduction in bile acid transport. The authors interpreted this as evidence of evolutionary plasticity in which NTCP can evolve resistance via mutations that compromise its native solute-transport role.
The team supplemented functional experiments with molecular dynamics simulations to probe structural consequences of the substitutions. Simulations suggested that lion-NTCP adopts a conformation in which bending of a transmembrane helix enlarges the entire bile acid tunnel. That alteration, investigators reported, would likely disrupt compatibility with the preS1 domain of hepadnavirus envelope proteins. The modeled conformational change therefore offers a structural explanation for simultaneous loss of viral binding and impaired transporter throughput.
These computational results dovetail with the mutagenesis data: residues 191 and 268 appear to influence helix geometry and tunnel dimensions, and those geometrical changes in turn alter both ligand (bile acid) passage and viral peptide docking. The authors noted that the simulations do not prove mechanism by themselves, but they provide a plausible mechanistic link between sequence variation and functional outcome.
Functional relevance extended beyond recombinant systems. The investigators demonstrated productive infection in primary cat hepatocytes expressing cat-NTCP, confirming that the receptor activity observed in vitro translates into infection of native feline liver cells. Short, clear infection assays produced replicative readouts in primary cells, establishing cat-NTCP as a bona fide receptor in a physiologically relevant context.
The study also reported that the same NTCP differences determined host susceptibility to another hepadnavirus that infects domestic cats. Species-specific NTCP variation therefore not only governs interaction with human-derived HBV components like preS1, but it also shapes susceptibility to feline-adapted hepadnaviruses.
This report appears as a preprint and has not been peer reviewed; the authors explicitly stated that status. The source did not provide detailed methodological parameters for some assays in the abstract, and full experimental protocols reside in the preprint and supplementary files. Investigators noted molecular dynamics as supportive rather than definitive evidence for the structural mechanism linking residues 191 and 268 to tunnel geometry and viral docking. The study did not report in vivo infection outcomes or population-level prevalence of the identified NTCP variants among wild and captive felid populations; those remain open questions.
Unanswered items documented by the authors include whether additional NTCP positions modulate subtler aspects of transporter function and viral compatibility, and how natural selection has balanced transporter utility against viral resistance in different felid lineages. The preprint format means independent replication and peer review are necessary next steps to validate the mutational and structural claims. Readers should consult the full preprint and supplementary material for experimental detail and raw data.